PLIB_ELACL
ID PLIB_ELACL Reviewed; 332 AA.
AC C0STK7;
DT 02-JUN-2021, integrated into UniProtKB/Swiss-Prot.
DT 26-MAY-2009, sequence version 1.
DT 29-SEP-2021, entry version 29.
DE RecName: Full=Phospholipase A2 inhibitor beta {ECO:0000303|PubMed:19673083};
DE Short=PLI-beta {ECO:0000303|PubMed:19673083};
DE Short=beta-PLI;
DE Flags: Precursor;
OS Elaphe climacophora (Japanese rat snake) (Coluber climacophorus).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC Serpentes; Colubroidea; Colubridae; Colubrinae; Elaphe.
OX NCBI_TaxID=31143;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 24-30, SUBCELLULAR
RP LOCATION, AND SUBUNIT.
RC TISSUE=Liver, and Serum;
RX PubMed=19673083; DOI=10.1016/j.toxicon.2009.02.001;
RA Shirai R., Toriba M., Hayashi K., Ikeda K., Inoue S.;
RT "Identification and characterization of phospholipase A2 inhibitors from
RT the serum of the Japanese rat snake, Elaphe climacophora.";
RL Toxicon 53:685-692(2009).
CC -!- FUNCTION: Inhibits the enzymatic activity of the basic phospholipase A2
CC (PLA2). {ECO:0000269|PubMed:19673083}.
CC -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:19673083}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:19673083}.
CC Note=Secreted in plasma. {ECO:0000269|PubMed:19673083}.
CC -!- MISCELLANEOUS: Concentration of this protein in the serum is 8-fold
CC lower than in the E.quadrivirgata (another non-venomous snake) serum.
CC This difference may reflect the difference in the food habits of these
CC snakes. E.quadrivirgata preys upon snakes including the venomous
CC snakes, whereas E.climacophora only preys upon small mammals and birds.
CC {ECO:0000269|PubMed:19673083}.
CC -!- SIMILARITY: Belongs to the beta-type phospholipase A2 inhibitor family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AB462511; BAH47549.1; -; mRNA.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0019834; F:phospholipase A2 inhibitor activity; IEA:UniProtKB-KW.
DR Gene3D; 3.80.10.10; -; 2.
DR InterPro; IPR000483; Cys-rich_flank_reg_C.
DR InterPro; IPR001611; Leu-rich_rpt.
DR InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR InterPro; IPR032675; LRR_dom_sf.
DR Pfam; PF00560; LRR_1; 1.
DR Pfam; PF13855; LRR_8; 2.
DR SMART; SM00369; LRR_TYP; 6.
DR SMART; SM00082; LRRCT; 1.
DR PROSITE; PS51450; LRR; 7.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Glycoprotein; Leucine-rich repeat;
KW Phospholipase A2 inhibitor; Repeat; Secreted; Signal.
FT SIGNAL 1..23
FT /evidence="ECO:0000269|PubMed:19673083"
FT CHAIN 24..332
FT /note="Phospholipase A2 inhibitor beta"
FT /evidence="ECO:0000305|PubMed:19673083"
FT /id="PRO_5002903549"
FT REPEAT 78..101
FT /note="LRR 1"
FT /evidence="ECO:0000255"
FT REPEAT 103..125
FT /note="LRR 2"
FT /evidence="ECO:0000255"
FT REPEAT 127..149
FT /note="LRR 3"
FT /evidence="ECO:0000255"
FT REPEAT 150..173
FT /note="LRR 4"
FT /evidence="ECO:0000255"
FT REPEAT 175..197
FT /note="LRR 5"
FT /evidence="ECO:0000255"
FT REPEAT 198..221
FT /note="LRR 6"
FT /evidence="ECO:0000255"
FT REPEAT 223..245
FT /note="LRR 7"
FT /evidence="ECO:0000255"
FT REPEAT 247..269
FT /note="LRR 8"
FT /evidence="ECO:0000255"
FT DOMAIN 280..331
FT /note="LRRCT"
FT /evidence="ECO:0000255"
FT CARBOHYD 35
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT CARBOHYD 232
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT CARBOHYD 272
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
SQ SEQUENCE 332 AA; 37244 MW; 3B8E29357C01D835 CRC64;
MKSSVPSLLF VSLVMSLNSY TQQVLYCPPD PAPENITEFV CNSPSLHEFP TGFPVRTKII
SVEFTQVSSL GVEALQGLPN LQELHLSNNR LKTLPSGLFR NLPELHTLDL STNLLEDLPP
EIFTSTTSLT LLSISENRLA KLRLSWFETL KELRILSLDN NQLKEVPISC FDKLEKLTFL
DLSSNHLHRL SPDMFSGLDN LERLSLENNP IRCIAPKSFH GRPKLSIISL KNCSLTNIIT
GVFQPLNHXV LLDLSDNELT MLDPPVAIPS ANLSLDLTGN PWACNCRMDN LLTWVKEHKI
DLYSKQEIVC AFPKSFKGEE ATSLHRSQIC PC